BUDGET OZEMPIC WEIGHT LOSS
Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?
Wockhardt's Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Compared to Novo Nordisk's Ozempic, Zaynich’s $25 billion potential counters global antibiotic resistance.
Beware of weight loss medications; they can make you go blind
A recent study conducted by researchers at Massachusetts Eye and Ear hospital has found a significant link between popular weight loss drugs containing semaglutide and an increased risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a rare condition causing sudden vision loss in one eye. The study, published in JAMA Ophthalmology, revealed that obese patients using these medications were over seven times more likely to develop NAION, while diabetic patients faced more than four times the risk.
India to make drugs for diabetes, obesity under PLI by 2026, says report
India plans to incentivize local manufacturing of GLP-1 drugs, crucial for treating diabetes and obesity, starting in 2026, as per a government official speaking to Reuters. These drugs, originally approved for diabetes treatment, are also used for obesity due to their ability to slow digestion and reduce appetite. Novo Nordisk's patent on semaglutide, a key ingredient in popular drugs like Wegovy and Ozempic, is set to expire in India by 2026. Indian companies are already preparing to manufacture these drugs under the government's production-linked incentive (PLI) scheme.
Biocon seeks partner to test generic Wegovy, Ozempic in China
India's Biocon is seeking a Chinese partner to conduct clinical trials on generic versions of Novo Nordisk's popular diabetes drug Ozempic and weight loss treatment Wegovy. Biocon aims to eventually launch these generics globally, with plans to find a partner for the trials on over 500 patients in China, citing the substantial investment required. The move comes ahead of the patent protection expiry on key ingredients in the drugs in 2026.
Ozempic frenzy lures rich Indians to brave the gray market
People are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying counterfeit formulas online, and importing boxes from Europe. The treatments have sparked extensive media coverage, fueling a high demand. According to Goldman Sachs Research, the anti-obesity medication market could hit $100 billion by 2030. In contrast, Indians have largely been observers in this global frenzy over the new weight-loss solutions.
Ozempic: Bengaluru is the secret ingredient behind the wonder weight loss drugs' success
Novo Nordisk's India team played a pivotal role in the success of Ozempic, a semaglutide-based drug for diabetes and weight management. The Bengaluru-based Global Business Services unit collaborated on clinical trials and biostatistics. Despite global demand, Ozempic's availability in India remains uncertain due to supply challenges, with significant hiring planned to bolster Novo Nordisk's workforce in India.
- Go To Page 1
New study warns of serious side effects from popular weight loss drugs Wegovy and Ozempic, finds they may paralyse stomach
A recent US study has found that weight loss medications like Wegovy and Ozempic may increase the risk of abdominal paralysis, characterized by delayed stomach emptying. The study, presented at Digestive Disease Week 2024, indicates a 30% higher risk for users of these drugs. Experts emphasize the need for awareness and medical monitoring of potential gastrointestinal side effects.
Massive fire at Danish pharma giant Novo Nordisk
A massive fire broke out at a Novo Nordisk office building in Copenhagen, prompting the evacuation of all occupants. Around 100 firefighters worked to extinguish the blaze that spread from a construction site to an adjacent building. There were no injuries reported nor was there any impact on drug production.
Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India
Doctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resort for some. “I would rather go for these short cuts that the pharma industry offers than go under the knife for my appearance,” says Rajput. The drugs — Wegovy and Ozempic — which have the same ingredient, semaglutide, are all the rage ever since entrepreneur Elon Musk tweeted about it.
Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot
Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market.
Eli Lilly in advanced clinical trials for its weight-loss pill
Eli Lilly has commenced phase three clinical trials in India for a new oral weight-loss drug called orforglipron. The trials aim to assess its safety and efficacy compared to insulin glargine in individuals with Type 2 diabetes and obesity or overweight at an increased cardiovascular risk. The company's spokesperson in India mentioned ongoing clinical studies on novel products, including orforglipron.
Novo Nordisk to buy Cardior Pharma for up to $1 billion
Novo Nordisk A/S bought Cardior Pharmaceuticals for $1 billion to enhance cardiovascular treatments. Cardior's microRNA-targeting therapies aim to improve heart function, aligning with Novo's focus on diabetes and obesity history.
India pharma companies develop versions of Wegovy to get in on weight-loss windfall
Indian drugmakers are developing their versions of Novo Nordisk's weight-loss treatment, Wegovy, aiming to capitalize on the growing weight-loss market, expected to reach $100 billion a year by the end of the decade. Companies like Sun Pharma, Cipla, Dr Reddy's, and Lupin are working on Wegovy alternatives as Novo Nordisk struggles to meet global demand.
Best rice in India- Here are the Top 10 picks just for you
In this article, we have brought the best of the best rice varieties, each one of them is a product of careful cultivation and aged perfection. These are some healthier options that do not compromise on taste and one of the best brands with an age old promise of quality.
Budget Ozempic: Know about this weight loss trend on Tik Tok and its associated risks
In recent years, Ozempic, the winning diabetic drug is very much in demand, taking the world of weight loss by storm. Here's everything to know more
What other health conditions might weight-loss drugs treat?
New data suggests that semaglutide may also cut the risk of stroke or heart attack, and may delay the progression of kidney disease in diabetes patients.
Weight-loss drugs: Who, and what, are they good for?
The new drugs are known as GLP-1 agonists, which mimic the activity of a hormone that slows digestion and helps people feel full for longer. In clinical trials, people lost 15% to 20% of their body weight, depending on the drug. Nearly 120 million American adults could be eligible for treatment, while Novo says its target market is more than 760 million people with obesity worldwide.
Why is Oprah Winfrey facing criticism for using weight-loss drug
Oprah Winfrey's weight-loss journey sparks controversy as she discloses reliance on undisclosed medication, challenging perceptions amid criticism and support. Amidst debates, she opens up about the emotional toll of body scrutiny and her pursuit of a healthier life post-surgery.
What is Ozempic? Exploring Hollywood's viral obsession and its weight loss appeal
Hollywood’s caught onto Ozempic! Initially for Type 2 diabetes, the FDA-approved drug, semaglutide (marketed as Ozempic), has become a celeb-driven weight loss trend. Amid shortages and denials, stars like Amy Schumer openly discuss its effects. Concerns arise about "Ozempic face" – facial sagging due to rapid weight loss. Stars have mixed thoughts – cautionary or critical – sparking a debate on bodies and fame's influence.
How well-off Brits still buy Ozempic online for weight loss
The demand for the diabetes drug Ozempic, known for its weight-loss effects, has led to shortages in countries like Britain and the United States. A contrast in access reveals that those with means can purchase it online for weight loss, despite government restrictions. The shortage, caused by overwhelming demand, is impacting diabetes patients dependent on the NHS, jeopardizing their health.
What's behind the scramble for semaglutide?
The global demand for the diabetes medicine Ozempic, containing semaglutide, is causing shortages in several countries due to its off-label use for weight loss. Novo Nordisk, the manufacturer, cites ongoing supply constraints. The company plans a $6 billion investment by 2029 to boost production. Britain and Belgium have restricted prescriptions for weight loss, and Germany considers banning exports due to affordability-driven demand.
Is Sharon Osbourne’s dramatic weight loss of 100 Pounds due to Ozempic? TV star reveals the truth
Renowned TV personality and podcast host Sharon Osbourne openly discussed her weight-loss journey, crediting the drug Ozempic for her notable transformation. While acknowledging the popularity of celebrities utilizing the drug for weight management, Osbourne also cautioned potential users.
Headline: 5 Actors Who Have Openly Talked about Taking Ozempic for Weight Loss
Hollywood actors are weighing on with their opinions on the weight-loss drug Ozempic and questioning the craze for getting thinner.
Fake weight loss injections leave people in comas, urgent safety alert issued
Fake weight loss injections, falsely marketed as Ozempic or Saxenda, have triggered significant safety alarms in the United Kingdom. Authorities are cautioning the public about the substantial risks associated with these counterfeit products, as several individuals have encountered life-threatening medical complications.
Fake Ozempic pens circulating in Europe, watchdogs warn
Counterfeit injection pens falsely labeled as Ozempic, a popular diabetes drug also used for weight loss, have been discovered in Europe, according to drug authorities. The fake pens originated from wholesalers in Austria and Germany, and found at some wholesalers in the EU and UK.
Demand for weight-loss drugs fuels global rise in counterfeits
The increasing demand for weight-loss drugs such as Novo Nordisk's Ozempic has led to a rise in counterfeit versions of these medications. Law enforcement agencies, anti-counterfeiting organizations, and public health officials are collaborating to combat this issue. The popularity of weight-loss drugs has made them a target for criminal organizations. Novo Nordisk and Eli Lilly, the manufacturers of these drugs, are working with various agencies to identify and deter counterfeit products.
Corporate America weighs risks of the Ozempic effect
U.S. companies in various sectors, including food and beverage, medical devices, and dialysis services, are facing questions from investors regarding the impact of weight-loss drugs on their future sales. Companies like Conagra and Walmart are considering potential changes in portion sizes and expect increased revenues from health and wellness products due to the popularity of these drugs. On the other hand, companies like PepsiCo and Abbott Laboratories do not anticipate a significant impact on their sales.
Nestlé responds to weight-loss drug surge: Developing health aids for Ozempic, Wegovy users
Nestlé, the global food leader, is responding to the growing trend of appetite-suppressing weight-loss medications like Ozempic, Wegovy, and Mounjaro by innovating complementary products. These pharmaceutical advancements have prompted considerations regarding their potential influence on food sales and the financial performance of the food industry.
Hollywood's blockbuster weight loss drugs are becoming all the rage among affluent Indians
According to doctors and fitness experts, queries come in every other day from (well-heeled) patients, asking whether they can take the expensive, injectable drugs to shed those stubborn kilos. “It’s coming up in conversations everywhere. Patients ask me about it all the time,” says Ambrish Mithal, chairman and head of endocrinology, Max Healthcare. There are a lot of people interested in taking Ozempic because “the weight loss is so dramatic”, says Kiran Sethi, medical director, Isya Aesthetics.
Load More
